Practice question

Monascus purpureus during fermentation produces monacolin K, chemically identical to lovastatin. It competitively inhibits HMG-CoA reductase, the rate-limiting enzyme of hepatic cholesterol biosynthesis, thereby reducing endogenous cholesterol synthesis and lowering blood cholesterol commercially.